SSO Names Chandrakanth Are, MBBS, MBA, Chief Executive Officer of Global Forum of Cancer Surgeons
As a member of the Global Forum of Cancer Surgeons, the Society of Surgical Oncology (SSO) is pleased to announce that Chandrakanth Are, MBBS, MBA, FSSO, FRCS, FACS, has been named Chief Executive Officer of the Global Forum of Cancer Surgeons.
Chandrakanth Are, MBBS, MBA, FSSO, FRCS, FACS
Dr. Are holds the title of Jerald L. and Carolynn J. Varner Professor of Surgical Oncology and Global Health. He is Associate Dean for Graduate Medical Education for the College of Medicine and Vice-Chair for Education in the Department of Surgery. He also serves as the Surgical Director for the Davis Global Center, the simulation center at the University of Nebraska Medical Center.
Dr. Are has lived, trained, and worked in various health-care systems worldwide. He obtained his medical degree from Osmania Medical College in Hyderabad, India. He then received his Fellowship from the Royal College of Surgeons in Ireland. Dr. Are completed his general surgery residency at Johns Hopkins Hospital, Baltimore, and fellowship in surgical oncology at the Memorial Sloan Kettering Cancer Center, New York. Dr. Are has an Executive MBA degree from the University of Omaha.
Dr. Are is involved in research with multiple publications. He is Director of two national and four international research collaboratives and is the Founding Editor-in-Chief of the peer-reviewed Graduate Medical Education Research Journal. He serves on the editorial boards of several journals. At the national level, he serves on the Residency Review Committee for Surgery at the Accreditation Council for Graduate Medical Education and on the Board of Scientific Advisors of the National Cancer Institute.
The Global Forum of Cancer Surgeons was formed in March 2017 at the Annual Meeting of the Society of Surgical Oncology. The group was established to address the lack of adequate surgical care for patients with cancer globally and create a framework to improve the delivery of surgical care to patients with cancer through global collaborative efforts.